Intelligent Bio Solutions Inc.
INBS
$2.15
-$0.05-2.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.25M | -2.69M | -2.78M | -2.98M | -1.97M |
| Total Depreciation and Amortization | 307.60K | 303.10K | 287.70K | 327.50K | 290.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.00K | 73.70K | 82.70K | 174.20K | -183.20K |
| Change in Net Operating Assets | -438.90K | -78.40K | -530.20K | 29.40K | -1.01M |
| Cash from Operations | -2.32M | -2.39M | -2.94M | -2.45M | -2.87M |
| Capital Expenditure | -8.90K | -- | -167.30K | 2.60K | -56.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.90K | -- | -167.30K | 2.60K | -56.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 652.40K | 42.50K | 5.30K | 13.21M | 1.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 3.04M |
| Repurchase of Preferred Stock | -- | -- | -- | -3.04M | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.60K | -- | -- | 592.40K | -592.40K |
| Cash from Financing | 631.70K | 42.50K | 5.30K | 10.77M | 3.79M |
| Foreign Exchange rate Adjustments | -45.30K | 30.10K | 12.60K | -46.50K | 72.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.75M | -2.31M | -3.09M | 8.28M | 932.60K |
